相关实验视频
Updated: Jun 12, 2025
07:31
Nitropeptide Profiling and Identification Illustrated by Angiotensin II
Published on: June 16, 2019
5.7K
类和类的铁酶抑制剂
Fosca Errante1, Lucrezia Sforzi1, Claudiu T Supuran2
1Interdepartmental Laboratory of Peptide and Protein Chemistry and Biology, University of Florence, Sesto Fiorentino, Florence, Italy; Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Sesto Fiorentino, Florence, Italy.
The Enzymes
|September 20, 2024
概括
类提供了安全有效的替代传统的皮肤美白剂,通过抑制激素酶,黑色素生产的关键酶. 这些铁酶抑制剂 (TIPs) 可以进行修改,以提高稳定性和双重功能.
科学领域:
- 生物化学 生化学
- 皮肤病学 皮肤病学
- 化品科学 化品科学
背景情况:
- 人体皮肤中的黑色素生产 (黑色素生成) 涉及酶活性,主要由铁酶 (TYR) 进行.
- TYR催化了黑色素合成中的关键步骤,使其成为控制多色素的目标.
- 现有的TYR抑制剂包括小分子,但在特异性,安全性和有效性方面具有优势.
研究的目的:
- 探索氨酸酶抑制剂 (TIPs) 作为低颜色剂的潜力.
- 与传统的小分子抑制剂相比,审查TIPs的分类和优势.
- 讨论加强TIP稳定性和功能性的战略.
主要方法:
- 对氨酶抑制和基于的治疗方法的现有文献的审查.
- 基于其原产地 (天然,混合,合成) 的TIP分类.
- 对基修饰策略的分析 (骨干变异,非正规氨基酸,型模拟剂,结合).
主要成果:
- 类是具有高特异性的多功能分子,可提高安全性和耐受性.
- 可以根据原产地对TIP进行分类,并提供一种有前途的方法来调节多颜色.
- 基修饰可以增强对蛋白质分解的稳定性,并使双重功能剂成为可能.
结论:
- 铁酶抑制剂代表了化品和皮肤病学应用中皮肤色调调节的重大进步.
- 固有的特异性和修饰潜力使得在氨酶抑制方面优于传统的小分子.
- 未来的研究可以专注于开发先进的TIP,提高稳定性和有针对性的交付,以改善低颜色效应.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:24Glucagon-like Receptor Agonists
305
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
305
01:23Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
01:26Receptor Tyrosine Kinases
12.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.5K
01:19Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K